Trial intelligence / Profile preview

Comparison of Atazanavir/Ritonavir vs Nevirapine on Truvada Backbone

NCT00552240Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Sep 2007
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Started Sep 2007; status: completed.

02

Drugs

nevirapine
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT00552240.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00552240.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call